Ofatumumab With IVAC Salvage Chemotherapy in Diffuse Large B Cell Lymphoma Patients

NCT01481272 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

77

Enrollment

NETWORK

Sponsor class

Conditions

Diffuse Large B Cell Lymphoma

Interventions

DRUG: Ofatumumab
DRUG: Etoposide
DRUG: Ifosfamid
DRUG: Mesna
DRUG: Cytarabine
DRUG: Methotrexate
DRUG: Leukovorin
DRUG: Granulocyte-Colony Stimulating Factor

Sponsor

Polish Lymphoma Research Group